Polymer–Protein Conjugates: From Pegylation and Beyond helps researchers by offering a unique reference and guide into this fascinating area. Sections cover the challenges surrounding the homogeneity of conjugates, their purity and polymer toxicity on long-term use, and how to deal with the risk of immunogenicity. These discussions help researchers design new projects by taking into account the latest innovations for safe and site selective polymer conjugation to proteins. PEG has been the gold standard and likely will play this role for many years, but alternatives are coming into the market, some of which have already been launched.
After five decades of improvements, the ideas in this book are entering into a new era of innovation because of the advances in genetic engineering, biochemistry and a better understanding of the results from clinical use of PEG conjugates in humans.

• Provides an overview on the state-of-the-art of protein polymer conjugation
• Presents both the pros and cons of polymer-protein conjugates from the point-of-view of their clinical outcomes
• Outlines advantages and potential risks of present technology based on PEG
• Offers new alternatives for PEG and new approaches for on site-selective protein modification
• Identifies future direction of research in this field